Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists
- PMID: 1317544
- DOI: 10.1016/0304-3959(92)90200-U
Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists
Abstract
Interactions between selective opioid agonists acting at spinal mu-, delta-, and kappa-opioid receptors were evaluated by co-administering a low-antinociceptive dose of the selective delta-agonist, DPDPE, or the selective kappa-agonist, U50,488H, with sequentially increasing doses of the selective mu-agonist, DAMGO, intrathecally. Antinociceptive synergy (i.e., a more than additive antinociceptive effect) was observed with both combinations of opioid agonists tested. The demonstration of antinociceptive synergy suggests that the subtypes of spinal opioid receptors can act, at least in part, through a common neural circuit. Since our measure of antinociception, the Randall-Selitto paw-withdrawal test, is dependent on a normally functioning motor system, we also evaluated the effects of these same combinations of opioid peptides on motor coordination using a rotarod treadmill. A low-antinociceptive dose of DPDPE or U50,488H co-administered intrathecally, with sequentially increasing doses of DAMGO, did not worsen the decrement in rotarod performance observed with the same doses of DAMGO administered as a single agent. In fact, the low-antinociceptive dose of DPDPE significantly attenuated the decrease in rotarod performance produced when the same dose of DAMGO was administered as a single agent. The results of this study suggest that intrathecal combinations of selective mu- with both delta- or kappa-selective opioid agonists can produce antinociceptive synergy without producing an increase in motor side effects.(ABSTRACT TRUNCATED AT 250 WORDS)
Comment in
-
Comments on Miaskowski et al., Pain 49 (1992) 137-144.Pain. 1992 Dec;51(3):383. doi: 10.1016/0304-3959(92)90227-3. Pain. 1992. PMID: 1337199 No abstract available.
-
A further comment on testing for drug synergism.Pain. 1992 Dec;51(3):381-382. doi: 10.1016/0304-3959(92)90225-Z. Pain. 1992. PMID: 1491866 No abstract available.
-
Comments on Tallarida and Miaskowski et al.Pain. 1992 Dec;51(3):382-383. doi: 10.1016/0304-3959(92)90226-2. Pain. 1992. PMID: 1491867 No abstract available.
Similar articles
-
Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.Brain Res. 1992 Nov 6;595(1):32-8. doi: 10.1016/0006-8993(92)91449-o. Brain Res. 1992. PMID: 1334770
-
Contribution of supraspinal mu- and delta-opioid receptors to antinociception in the rat.Eur J Pharmacol. 1991 Dec 3;205(3):247-52. doi: 10.1016/0014-2999(91)90905-6. Eur J Pharmacol. 1991. PMID: 1667910
-
Analgesic synergy and improved motor function produced by combinations of mu-delta- and mu-kappa-opioids.Brain Res. 1990 Oct 22;530(2):290-4. doi: 10.1016/0006-8993(90)91297-t. Brain Res. 1990. PMID: 1979930
-
Role of opioidergic and serotonergic mechanisms in cough and antitussives.Pulm Pharmacol. 1996 Oct-Dec;9(5-6):349-56. doi: 10.1006/pulp.1996.0046. Pulm Pharmacol. 1996. PMID: 9232674 Review.
-
Biphalin-A Potent Opioid Agonist-As a Panacea for Opioid System-Dependent Pathophysiological Diseases?Int J Mol Sci. 2021 Oct 21;22(21):11347. doi: 10.3390/ijms222111347. Int J Mol Sci. 2021. PMID: 34768778 Free PMC article. Review.
Cited by
-
Preclinical Testing of Nalfurafine as an Opioid-sparing Adjuvant that Potentiates Analgesia by the Mu Opioid Receptor-targeting Agonist Morphine.J Pharmacol Exp Ther. 2019 Nov;371(2):487-499. doi: 10.1124/jpet.118.255661. Epub 2019 Sep 6. J Pharmacol Exp Ther. 2019. PMID: 31492823 Free PMC article.
-
Topical Application of Loperamide/Oxymorphindole, Mu and Delta Opioid Receptor Agonists, Reduces Sensitization of C-fiber Nociceptors that Possess NaV1.8.Neuroscience. 2020 Oct 15;446:102-112. doi: 10.1016/j.neuroscience.2020.08.022. Epub 2020 Aug 25. Neuroscience. 2020. PMID: 32858141 Free PMC article.
-
Evaluation of the interaction of mu and kappa opioid agonists on locomotor behavior in the horse.Can J Vet Res. 1993 Apr;57(2):106-9. Can J Vet Res. 1993. PMID: 8490803 Free PMC article.
-
Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors.Br J Pharmacol. 2015 Jan;172(2):642-53. doi: 10.1111/bph.12774. Epub 2014 Nov 24. Br J Pharmacol. 2015. PMID: 24827408 Free PMC article.
-
The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats.Psychopharmacology (Berl). 2021 Dec;238(12):3463-3476. doi: 10.1007/s00213-021-05965-x. Epub 2021 Aug 25. Psychopharmacology (Berl). 2021. PMID: 34430992 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials